(Q34472174)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9630590%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

review article

1 reference

title

'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9630590%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9630590%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

V Di Marzo

series ordinal

1

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9630590%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

number of pages

23

1 reference

Biochimica et Biophysica Acta

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9630590%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

1392

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9630590%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9630590%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

153-175

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9630590%20AND%20SRC:MED&resulttype=core&format=json

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

The Total Synthesis of Cannabinoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Pharmacology of cannabinoid CB1 and CB2 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Anandamide, an endogenous cannabinomimetic eicosanoid: ‘Killing two birds with one stone’

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Effects of two endogenous fatty acid ethanolamides on mouse vasa deferentia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

N-acylated glycerophospholipids and their derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Chemical characterization of a family of brain lipids that induce sleep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Cerebrodiene, arachidonyl-ethanolamide, and hybrid structures: potential for interaction with brain cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Anandamide may mediate sleep induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

cis-9,10-octadecenoamide, an endogenous sleep-inducing CNS compound, inhibits lymphocyte proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Molecular characterization of a peripheral receptor for cannabinoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Is the cannabinoid CB1 receptor a 2-arachidonoylglycerol receptor? Structural requirements for triggering a Ca2+ transient in NG108-15 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Inhibition by 2-arachidonoylglycerol, a novel type of possible neuromodulator, of the depolarization-induced increase in intracellular free calcium in neuroblastoma x glioma hybrid NG108-15 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Regulation of a neuronal form of focal adhesion kinase by anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Identification and characterization of the leech CNS cannabinoid receptor: coupling to nitric oxide release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Morphine- and anandamide-stimulated nitric oxide production inhibits presynaptic dopamine release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Tetrahydrocannabinol inhibition of macrophage nitric oxide production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

The endogenous cannabimimetic eicosanoid, anandamide, induces arachidonate release in J774 mouse macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Receptor mediation in cannabinoid stimulated arachidonic acid mobilization and anandamide synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

(R)-methanandamide inhibits receptor-induced calcium responses by depleting internal calcium stores in cultured astrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Isolation, identification and synthesis of an endogenous arachidonic amide that inhibits calcium channel antagonist 1,4-dihydropyridine binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Effects of anandamide and arachidonic acid on specific binding of (+) -PN200-110, diltiazem and (-) -desmethoxyverapamil to L-type Ca2+ channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Anandamide, an endogenous cannabinoid, inhibits Shaker-related voltage-gated K+ channels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

High-performance liquid chromatography and fluorometric detection of arachidonylethanolamide (anandamide) and its analogues, derivatized with 4-(N-chloroformylmethyl-N-methyl)amino-7-N,N-dimethylaminosulp honyl-2,1 ,3- benzoxadiazole (DBD-COCl).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Enzymatic synthesis of anandamide, an endogenous cannabinoid receptor ligand, through N-acylphosphatidylethanolamine pathway in testis: involvement of Ca(2+)-dependent transacylase and phosphodiesterase activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Analysis of anandamide, an endogenous cannabinoid substance, and of other natural N-acylethanolamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Production and physiological actions of anandamide in the vasculature of the rat kidney.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Anandamide and other N-acylethanolamines in mouse peritoneal macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

A second endogenous cannabinoid that modulates long-term potentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

The sleep inducing factor oleamide is produced by mouse neuroblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Reversible hydrolysis and synthesis of anandamide demonstrated by recombinant rat fatty-acid amide hydrolase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

The cloned rat hydrolytic enzyme responsible for the breakdown of anandamide also catalyzes its formation via the condensation of arachidonic acid and ethanolamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Potential biosynthetic connections between the two cannabimimetic eicosanoids, anandamide and 2-arachidonoyl-glycerol, in mouse neuroblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Occurrence and metabolism of anandamide and related acyl-ethanolamides in ovaries of the sea urchin Paracentrotus lividus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Metabolism of unique diarachidonoyl and linoleoylarachidonoyl species of ethanolamine and choline phosphoglycerides in rat testes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Alterations of fatty acyl turnover in macrophage glycerolipids induced by stimulation. Evidence for enhanced recycling of arachidonic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

The uterus is a potential site for anandamide synthesis and hydrolysis: differential profiles of anandamide synthase and hydrolase activities in the mouse uterus during the periimplantation period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Arachidonic acid and eicosanoids as targets and effectors in second messenger interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Fatty acid amide biosynthesis: a possible new role for peptidylglycine alpha-amidating enzyme and acyl-coenzyme A: glycine N-acyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Functional role of high-affinity anandamide transport, as revealed by selective inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Inhibition of anandamide amidase activity in mouse brain microsomes by cannabinoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma ‘anandamide amidohydrolase’

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Molecular characterization of human and mouse fatty acid amide hydrolases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Metabolism of anandamide, an endogenous cannabinoid receptor ligand, in porcine ocular tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Novel Inhibitors of Brain, Neuronal, and Basophilic Anandamide Amidohydrolase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Inhibition of anandamide hydrolysis in rat brain tissue by (E)-6-(bromomethylene) tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Brain and peripheral anandamide amidohydrolase and its inhibition by synthetic arachidonate analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

The effect of cannabidiol on mouse hepatic microsomal cytochrome P450-dependent anandamide metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Synthesis and cannabinoid receptor binding activity of conjugated triene anandamide, a novel eicosanoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

The effect of hydroxylation of linoleoyl amides on their cannabinomimetic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Brain cannabinoids in chocolate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

(R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

delta 9-Tetrahydrocannabinol and anandamide enhance the ability of muscimol to induce catalepsy in the globus pallidus of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

The endogenous cannabinoid receptor agonist anandamide impairs memory in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

The effects of anandamide on memory consolidation in mice involve both D1and D2 dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Long-term synaptic transformation of hippocampal CA1 gamma-aminobutyric acid synapses and the effect of anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Effects of anandamide (endogen cannabinoid) on anterior pituitary hormone secretion in adult ovariectomized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Arachidonyl ethanolamide (anandamide) activates the parvocellular part of hypothalamic paraventricular nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Further evidence for the presence of cannabinoid CB1 receptors in mouse vas deferens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Mechanism of the hypotensive action of anandamide in anesthetized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Endothelium-derived hyperpolarizing factor(s): updating the unknown

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

An endogenous cannabinoid as an endothelium-derived vasorelaxant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Ocular activity of topically administered anandamide in the rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Anandamide suppresses nitric oxide and TNF-alpha responses to Theiler's virus or endotoxin in astrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Evidence for a cannabinoid receptor in sea urchin sperm and its role in blockade of the acrosome reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Cannabinoid ligand-receptor signaling in the mouse uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Developmental aspects of anandamide: ontogeny of response and prenatal exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Atypical location of cannabinoid receptors in white matter areas during rat brain development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Bioactive long chain N-acylethanolamines in five species of edible bivalve molluscs. Possible implications for mollusc physiology and sea food industry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

The sleep-inducing lipid oleamide deconvolutes gap junction communication and calcium wave transmission in glial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Arachidonylethanolamide (anandamide) binds with low affinity to dihydropyridine binding sites in brain membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Studies on the effects of anandamide in rat hepatic artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Effects of topical alpha-substituted anandamides on intraocular pressure in normotensive rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Biphasic effects of anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

7 January 2021

Liquid chromatographic-atmospheric pressure chemical ionization mass spectrometric determination of anandamide and its analogs in rat brain and peripheral tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

7 January 2021

Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

7 January 2021

Characterization of glutamate-induced formation of N-acylphosphatidylethanolamine and N-acylethanolamine in cultured neocortical neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2898%2900042-3

7 January 2021

10.1016/S0005-2760(98)00042-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9630590%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference